Patient Guide: realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 25 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04981795
Status: 🟢 Enrolling Now
Condition: Diffuse Large B-cell Lymphoma
Phase: Research Study

Where You Can Participate

This study is available at 25 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Huntsville, Alabama
  • • Orange, California
  • • And 22 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL - Join Clinical Trial NCTNCT04981795

How to Join This Clinical Trial - NCTNCT04981795

Learn how to participate in this clinical trial studying an investigational therapy for Diffuse Large B-cell Lymphoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Diffuse Large B-cell Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Diffuse Large B-cell Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
Clinical trial phase - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04981795 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 25 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35211 - United States

Status: RECRUITING

Clinical Research Site

Huntsville, Alabama 35805 - United States

Status: RECRUITING

Clinical Research Site

Orange, California 92868 - United States

Status: RECRUITING

Clinical Research Site

Ames, Iowa 50010 - United States

Status: RECRUITING

Clinical Research Site

Des Moines, Iowa 50309 - United States

Status: RECRUITING

Clinical Research Site

New Orleans, Louisiana 70112 - United States

Status: COMPLETED

Clinical Research Site

Bethesda, Maryland 20817 - United States

Status: RECRUITING

Clinical Research Site

Ann Arbor, Michigan 48109 - United States

Status: RECRUITING

Clinical Research Site

Detroit, Michigan 48202 - United States

Status: RECRUITING

Clinical Research Site

Morristown, New Jersey 07960-6136 - United States

Status: RECRUITING

And 15 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this clinical trial for Diffuse Large B-cell Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships